Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Overview
Date Founded

1980

Headquarters

One Amgen Center Drive,Thousand Oaks, CA 91320-1799

Type of Company

Public

Employees (Worldwide)

24.3K

Industries

Biotechnology
Hospitals & Patient Services

Company Description

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Contact Data
Trying to get in touch with decision makers at Amgen, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Executive Director & Head of Global Media Relations

Senior Vice President, Manufacturing

Executive Director

Executive Vice President & Chief Financial Officer

Executive Vice President, General Counsel & Secretary

Senior Vice President & Chief Compliance Officer

Senior Vice President & Chief Information Officer

Executive Vice President & Chief Human Resource Officer

Senior Vice President & General Manager, Japan Asia-Pacific

Board of Directors

Chairman & Chief Executive Officer at Amgen, Inc.

Scientific Founder at Blueprint Medicines Corp.

Chairman & Chief Executive Officer at Northrop Grumman Systems Corp.

President at USC Norris Comprehensive Cancer Center

President & Chief Executive Officer at Carbon, Inc.

Operating Partner at FFL Partners LLC

Founder at Dragonfly Therapeutics, Inc.

Former Managing Director at General Wireless Operations, Inc.

Vice President for Research & Innovation at Duke University

Co-Founder at Compute Health Acquisition Corp.

Paths to Amgen, Inc.
Potential Connections via
Relationship Science
You
Amgen, Inc.
Owners & Shareholders
Details Hidden

CWGI is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach; (2) long-established, global research; (3) a multiple portfolio counselor system that combines teamwork with individual accountability; (4) experienced, long-tenured investment professionals; and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System wherein the assets of each fund are divided into smaller, more manageable portions. Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results and portfolio counselors are free to make their own decisions. Investment decisions are based on internal research.

Details Hidden

PRIMECAP Management aims to provide superior long-term investment results by utilizing fundamental research and bottom-up stock picking to construct portfolios. The firm looks for stocks that will outperform the market over a three to five-year horizon. PRIMECAP Management does not have a committee or small group that decides on whether or not to invest in an idea. Each portfolio manager makes an individual decision whether or not to invest in new ideas.

Details Hidden

MSWM assists in developing customized solutions for each client in Wealth Management Services (WMS) program. As part of the WMS agreement, the firm assists clients in developing their investment objectives and preparing an investment policy statement upon which Private Wealth Management (PWM)’s recommendations are based. When conducting their investment analysis, PWM applies the average expected return of each asset class within a portfolio, as well as historical risk and correlations between asset classes. MSWM provides ongoing investment and manager recommendations through one or more of the following investment advisory programs they offered: (1) affiliated and unaffiliated investment managers who manage separately managed accounts through Select UMA, Fiduciary Services, Consulting and Evaluation Services and the PWM Manager Assessment Program; (2) Global Investment Solutions; (3) the Portfolio Management Program; (4) affiliated and unaffiliated pooled investment vehicles; and (4) cash and cash equivalents (including sweep options). The pooled investment vehicles in which PWM invests may include open-end funds registered as investment companies with the SEC and investment vehicles that are not registered with the SEC. Pooled investment vehicles may also include ETFs, exchange traded trusts, and registered closed-end funds.

Recent Transactions
Details Hidden

Amgen, Inc. purchases TeneoBio, Inc.

Details Hidden

Amgen, Inc. purchases Five Prime Therapeutics, Inc.

Details Hidden

Amgen, Inc. purchases Rodeo Therapeutics Corp.

Transaction Advisors
Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Accountant

Advised onAmgen, Inc. purchases Immunex Corp.

Investment Advisor

Advised onAmgen, Inc. purchases Immunex Corp.

Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Advisors & Consultants
Advisor

Partner, Chief Financial Officer at Platinum Equity Advisors LLC

Advisor

Senior Partner, Finance at Apollo Global Management, Inc.

Advisor

President & Managing Director at Morgan Stanley Investment Management, Inc.

Clients

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

DaVita is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2012, DaVita operated or provided administrative services at 1,912 outpatient dialysis centers in 43 states in the United States, serving approximately 150,000 patients, and at 24 centers in five countries outside of the United States that serve approximately 1,000 patients.

Key Stats and Financials As of 2020
Market Capitalization
$115B
Total Enterprise Value
$158B
Earnings Per Share
$12.31
Revenue
$25.2B
Net Profit
$7.26B
Total Equity
$9.41B
TEVNet Income
21.81x
Debt TEV
0.21x
Enterprise Value / Sales
6.28x
Total Debt
$33.4B
Enterprise Value EBITDAOperating
12.58x
EBITDAMargin
49.76%
EBITDA
$12.6B
Three Year Compounded Annual Growth Rate Of Revenue
3.48%
Political Donations
$200
2014
$200
2014
$1,000
2014
Investments
Details Hidden

Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. It also develops instruments like GridIONTM and MinIONTM which are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. The firm's platform has a broad range of potential applications, including scientific research, personalized medicine, crop science and security and defense. The company was founded by Gordon Sanghera, Spike Willcocks and John Hagan Pryce Bayley in 2005 and is headquartered in Oxford, the United Kingdom.

Details Hidden

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Details Hidden

TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC.

Investors
Details Hidden

Partner at The Column Group LLC

Details Hidden

Limited Partner at Sutter Hill Ventures LLC

Details Hidden

Investor Director at Fallcon Solutions Ltd.

Suppliers
Healthpeak Properties, Inc. Real Estate | Irvine, CA

Healthpeak Properties, Inc. is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community(CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Medical Office segment includes pharmacies, hospital ancillary service space, and outpatient services such as diagnostic centers, rehabilitation clinics, and day-surgery operating rooms. The CCRC segment include independent living, assisted living, and skilled nursing units to provide a continuum of care in an integrated campus. The company was founded in March 1985 and is headquartered in Denver, CO.

Immunogen Inc. Medical Support Services | Waltham, MA

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.

Harvard Bioscience, Inc. Industrial Machinery & Manufacturing | Holliston, MA

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Competitors
Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Awards & Honors
Rank #130
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #130
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amgen, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amgen, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Amgen, Inc..